Is AptarGroup Inc (ATR) overvalued? · P/E 21, rev $3.58B
AptarGroup Inc (ATR) is a medical instruments & supplies company listed on NYSE.
This page asks whether AptarGroup Inc (ATR) looks expensive on cached numbers — not a short thesis.
Latest reported ATR revenue for 2024-12-31 was $3.58B. Net income was $374.2M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. ATR currently screens at market cap $7.66B and trailing P/E 20.5.
ATR currently screens at market cap $7.66B and trailing P/E 20.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ATR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ATR stock page for the full model, not this heading.
Not investment advice.